Medication to prevent antibiotic toxicity

The Hebrew University of Jerusalem and Israel’s Tissue Dynamics again used their “sensors on a chip” to bypass animal testing in developing a new treatment. They proved that the diabetic drug empagliflozin blocks the toxicity of aminoglycoside antibiotics in kidney disease patients.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *